Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical Gastrojejunostomy

Gastric outlet obstruction (GOO) occurs commonly in malignancies involving the periampullary region (cancers originating in the head of the pancreas, duodenum, bile duct, or ampulla) or the distal stomach. GOO not only causes debilitating symptoms such as nausea, vomiting, inability to tolerate oral intake, and prevents adequate nutritional intake. Therefore, providing therapy for GOO is imperative to improve the quality of life, and nutritional status of these patients, as well as allow them to continue receiving their cancer treatment

Trial Details

NCT ID
NCT05561907
Phase
NA
Sponsor
Northwell Health
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Surgical gastrojejunostomy (SGJ)
  • Endoscopic gastrojejunostomy (EGJ)
Locations (sample)
  • New Brunswick, New Jersey, United States|40.48622,-74.45182
  • Manhasset, New York, United States|40.79788,-73.69957
  • New Hyde Park, New York, United States|40.7351,-73.68791
  • New York, New York, United States|40.71427,-74.00597

Key Eligibility Criteria

  • Periampullary malignancy (pancreas, bile duct, ampulla, duodenum) extending to the distal duodenum (D3) or distal (antrum) gastric cancer
  • Symptoms of gastric outlet obstruction (at least 2 of 4 required):
  • post prandial vomiting,
  • abdominal pain,

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →